Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Julphar
Chubb
McKinsey
McKesson
Cantor Fitzgerald
Medtronic
Express Scripts
Chinese Patent Office

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087717

« Back to Dashboard

NDA 087717 describes DIPYRIDAMOLE, which is a drug marketed by Athenex Inc, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Teva Pharms Usa, West-ward Pharms Int, Barr, Glenmark Generics, Idt Australia Ltd, Impax Labs, Lannett, Murty Pharms, Oxford Pharms, Purepac Pharm, Watson Labs, and Zydus Pharms Usa Inc, and is included in twenty-two NDAs. It is available from ten suppliers. Additional details are available on the DIPYRIDAMOLE profile page.

The generic ingredient in DIPYRIDAMOLE is dipyridamole. There are eighteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.
Summary for 087717
Tradename:DIPYRIDAMOLE
Applicant:Barr
Ingredient:dipyridamole
Patents:0
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details
Pharmacology for NDA: 087717
Physiological EffectDecreased Platelet Aggregation
Medical Subject Heading (MeSH) Categories for 087717
Suppliers and Packaging for NDA: 087717
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIPYRIDAMOLE dipyridamole TABLET;ORAL 087717 ANDA Teva Pharmaceuticals USA, Inc. 0555-0286 0555-0286-02 100 TABLET, FILM COATED in 1 BOTTLE (0555-0286-02)
DIPYRIDAMOLE dipyridamole TABLET;ORAL 087717 ANDA Teva Pharmaceuticals USA, Inc. 0555-0286 0555-0286-05 1000 TABLET, FILM COATED in 1 BOTTLE (0555-0286-05)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength75MG
Approval Date:Oct 3, 1990TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Deloitte
AstraZeneca
Harvard Business School
Farmers Insurance
Healthtrust
US Department of Justice
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot